ArticleCurrent oncology (Toronto, Ont.)2024

Outcomes of First Subsequent Taxane Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Who Previously Received Docetaxel Intensification for Metastatic Castration-Sensitive Prostate Cancer.

Gabrielle Robin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.